MedPath

Comparison Between Two Techniques of Volemic Expansion in Hip Replacement Arthroplasty

Phase 4
Completed
Conditions
Hip Replacement Arthroplasty
Interventions
Drug: Ringer's lactate
Registration Number
NCT00542516
Lead Sponsor
University of Sao Paulo
Brief Summary

Currently the most use solution to volemic reposition in hip replacement arthroplasty is the crystalloid solution. This trial intends to compare two different volemic replacements: HES and Ringer's lactate. This research has been analyzing hemodynamic parameters and the coagulation status before and after the pre-expansion with the solutions above mentioned.

Detailed Description

This trial is randomized an blind to the physician who is analyzing the results.It has been select adults; both sex; ASA I and II. These patients must be submitted to hip arthroplasty replacement. The anesthesia technique is single shot spinal anesthesia. Primary endpoint: assessment alternative; technique replacement volemic with HES 130/04. Secondary endpoint: haemostatic abnormalities; blood loss; transfusion blood.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
48
Inclusion Criteria
  • Patients involved: adults, ASA I and II;
  • Surgery: hip replacement arthroplasty.
Exclusion Criteria
  • Allergy starch;
  • Anemia;
  • Dysfunction renal;
  • Heart insufficiency;
  • Morbid obesity.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Ringer's lactateRinger's lactatePre-expansion with Ringer's lactate
HES 130/04Hydroxyethyl StarchPre-expansion with HES
Ringer's lactateHydroxyethyl StarchPre-expansion with Ringer's lactate
Primary Outcome Measures
NameTimeMethod
HES expansion plasmatic efficacy24 hours
Secondary Outcome Measures
NameTimeMethod
Blood transfusion24 hours
Haemostatic alterations24 hours

Trial Locations

Locations (1)

Institute of Orthopedics and Traumatology of HCFMUSP

🇧🇷

São Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath